Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Kassem

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Pediatrics|June 1, 1996
Safety and pharmacokinetics of recombinant human superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndromeW N Rosenfeld, J M Davis, L Parton, et al.
Alimentary Pharmacology & Therapeutics|November 2, 2007
Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndromeS M Leventer, K Raudibaugh, C L Frissora, et al.
Undersea & Hyperbaric Medicine : Journal of the Undersea and Hyperbaric Medical Society, Inc|June 25, 2013
Hyperbaric oxygen and dental extractions in irradiated patients: short- and long-term outcomesMarvin Heyboer, Susan M Wojcik, John B McCabe, et al.
Neurology|July 1, 1997
Intrathecal administration of recombinant human superoxide dismutase 1 in amyotrophic lateral sclerosis: a preliminary safety and pharmacokinetic studyM E Cudkowicz, L Warren, J W Francis, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|July 6, 2000
Long-term follow-up of premature infants treated with prophylactic, intratracheal recombinant human CuZn superoxide dismutaseJ M Davis, S E Richter, S Biswas, et al.
Pediatrics|July 1, 1997
Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndromeJ M Davis, W N Rosenfeld, S E Richter, et al.
Lancet (London, England)|June 17, 2008
Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trialSarah A Frech, Herbert L Dupont, A Louis Bourgeois, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Pediatrics|June 1, 1996
Safety and pharmacokinetics of recombinant human superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndromeW N Rosenfeld, J M Davis, L Parton, et al.
Alimentary Pharmacology & Therapeutics|November 2, 2007
Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndromeS M Leventer, K Raudibaugh, C L Frissora, et al.
Undersea & Hyperbaric Medicine : Journal of the Undersea and Hyperbaric Medical Society, Inc|June 25, 2013
Hyperbaric oxygen and dental extractions in irradiated patients: short- and long-term outcomesMarvin Heyboer, Susan M Wojcik, John B McCabe, et al.
Neurology|July 1, 1997
Intrathecal administration of recombinant human superoxide dismutase 1 in amyotrophic lateral sclerosis: a preliminary safety and pharmacokinetic studyM E Cudkowicz, L Warren, J W Francis, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|July 6, 2000
Long-term follow-up of premature infants treated with prophylactic, intratracheal recombinant human CuZn superoxide dismutaseJ M Davis, S E Richter, S Biswas, et al.
Pediatrics|July 1, 1997
Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndromeJ M Davis, W N Rosenfeld, S E Richter, et al.
Lancet (London, England)|June 17, 2008
Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trialSarah A Frech, Herbert L Dupont, A Louis Bourgeois, et al.
Pageof 2